Sponsor:
Incyte Corporation
Code:
NCT07441694
Conditions
Myeloproliferative Neoplasms
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
INCA036978
Standard disease-directed therapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-19. This information was provided to ClinicalTrials.gov by Incyte Corporation on 2026-07-22.